Digital Cognitive Training in Older Adults
Effect of a Physical Acticity-Integrated Digital Cognitive Training Program on Cognitive Function and Physical Performance in Community-Dwelling Older Adults
The purpose of this clinical study is to evaluate the effects of a digital cognitive training program combined with physical activity on the cognitive and physical functions of community-dwelling older adults. For older adults, maintaining both mental and physical health is essential for overall well-being. This study hypothesizes that combining tablet-based brain exercises with short, physical activities will help improve participants' memory, thinking skills, and physical abilities, such as balance and walking.
Researchers aim to enroll approximately 35 community-dwelling older adults who are 65 years of age or older and capable of walking. Participants will be randomly assigned to one of two groups:
- Standard Intervention Group: Participants will attend a 50-minute session once a week for 10 weeks. During each session, they will use a tablet device for cognitive training focused on memory, attention, and executive functions. This training will be paused three times per session for about 3 minutes each to perform low-intensity, physical activities to music.
- Extended Intervention Group: Participants will participate in the same 10-week digital cognitive training and physical activity program as the standard group. In addition, they will receive additional home-based cognitive activities to complete once a week.
To measure the effectiveness of the program, researchers will assess all participants before the program starts and after the 10-week program ends. Assessments will evaluate cognitive function, including memory and attention, as well as physical functions, such as grip strength, leg strength, balance, walking speed, and muscle mass.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Community-dwelling older adults aged 65 years or older.
- Able to understand the purpose of the study and voluntarily consent to participate.
- Cognitively intact or presenting with mild subjective memory complaints without a diagnosis of dementia (e.g., MoCA score ≥ 23 or MMSE score ≥ 24).
- Able to walk independently without assistance (with or without assistive devices).
- Able to understand instructions and perform cognitive and physical training programs using digital devices.
Exclusion Criteria:
- Diagnosis of dementia or severe cognitive impairment.
- Severe visual or hearing impairment that interferes with participating in digital training or assessment.
- Acute or chronic neurological/musculoskeletal disorders that limit physical training (e.g., recent stroke, severe osteoarthritis).
- History of severe cardiovascular disease or unmanaged hypertension/diabetes.
- Current participation in other interventional clinical trials or similar cognitive/physical training programs.
- Inability to follow study instructions due to severe psychiatric illness or communication difficulties.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
アクティブコンパレータ:Standard Intervention Group
Participants will receive a 50-minute session consisting of tablet-based digital cognitive training combined with physical activities once a week for 10 weeks. |
A 10-week program where participants attend a 50-minute session once a week. Each session involves tablet-based digital cognitive training (focusing on memory, attention, and executive functions) combined with three 3-minute bouts of low-intensity, physical activities. |
|
実験的:Extended Intervention Group
Participants will receive the same 10-week program as the Standard Intervention Group (tablet-based digital cognitive training and seated physical activities). In addition, they will receive home-based cognitive activities to complete once a week. |
A 10-week program combining a once-weekly 50-minute center-based session (tablet-based cognitive training and seated physical activities) with additional home-based cognitive activities to be completed once a week. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
The Korean Version of Montreal Cognitive Assessment (MoCA-K)
時間枠:Baseline and 10 weeks
|
Cognitive function will be assessed using the Korean version of the Montreal Cognitive Assessment (MoCA-K). Total scores range from 0 to 30, where higher scores indicate better cognitive performance. |
Baseline and 10 weeks
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
The Short Physical Performance Battery (SPPB).
時間枠:Baseline and 10 weeks
|
Overall physical performance will be assessed using the Short Physical Performance Battery (SPPB). The SPPB evaluates lower extremity function through three components: standing balance, gait speed, and a 5-repetition chair stand test. Each component is scored from 0 to 4, yielding a total score ranging from 0 to 12. Higher scores indicate better physical function. |
Baseline and 10 weeks
|
|
Change in Grip Strength
時間枠:Baseline and 10 weeks
|
Handgrip strength will be measured using a hand dynamometer. Results are recorded in kilograms (kg), where higher values indicate greater upper body muscle strength. |
Baseline and 10 weeks
|
|
Change in Lower Extremity Strength
時間枠:Baseline and 10 weeks
|
Lower body strength will be assessed using the Five-times Sit-to-Stand test. Scores indicate the seconds of stands completed in 5 times, where a higher number indicates better lower extremity strength. |
Baseline and 10 weeks
|
|
Change in Dynamic Balance
時間枠:Baseline and 10 weeks
|
Dynamic balance will be assessed using the Timed Up and Go (TUG) test. Results are measured in seconds, where a lower time indicates better mobility and dynamic balance. |
Baseline and 10 weeks
|
|
Change in Static Balance
時間枠:Baseline and 10 weeks
|
Static balance will be assessed using the Balancia software by measuring COP sway path length under the eyes open and closed condition. Results are recorded in centimeters (cm), where lower values indicate better postural stability. |
Baseline and 10 weeks
|
|
Change in Gait velocity
時間枠:Baseline and 10 weeks
|
Gait velocity will be assessed using the GAITRite electronic walkway system. Results are measured in centimeters per second (cm/s), where higher values indicate better walking performance. |
Baseline and 10 weeks
|
|
Change in Gait cadence
時間枠:Baseline and 10 weeks
|
Gait cadence will be assessed using the GAITRite electronic walkway system. Results are measured in steps per minute (steps/min), where higher values indicate better gait rhythm and coordination. |
Baseline and 10 weeks
|
|
Change in Step Length
時間枠:Baseline and 10 weeks
|
Step length will be assessed using the GAITRite electronic walkway system. Results are measured in centimeters (cm), where higher values indicate better gait efficiency. |
Baseline and 10 weeks
|
|
Change in Stride Length
時間枠:Baseline and 10 weeks
|
Stride length will be assessed using the GAITRite electronic walkway system. Results are measured in centimeters (cm), where higher values indicate better mobility. |
Baseline and 10 weeks
|
|
Change in Skeletal Muscle Mass Index (SMI)
時間枠:Baseline and 10 weeks
|
Skeletal Muscle Mass Index (SMI) will be assessed using a Bioelectrical Impedance Analysis (BIA) device (InBody BWA). SMI is reported in kg/m², where higher values indicate greater skeletal muscle mass. |
Baseline and 10 weeks
|
|
Change in Subjective Memory Complaints (SMCQ-K)
時間枠:Baseline and 10 weeks
|
Subjective memory complaints will be assessed using the Subjective Memory Complaints Questionnaire (SMCQ-K). Scores range from 0 to 14, where higher scores indicate a higher level of subjective memory impairment. |
Baseline and 10 weeks
|
|
Change in Pain Intensity (NPRS)
時間枠:Baseline and 10 weeks
|
Pain intensity will be measured using the Numeric Pain Rating Scale (NPRS) for participants reporting pain. Scores range from 0 (no pain) to 10 (worst possible pain), where lower scores indicate reduced pain intensity. |
Baseline and 10 weeks
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (推定)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
その他の研究ID番号
- SYU 2026-09-027-002
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。